Skip to main content

Table 4 Change from baseline to SVR 12 in patients with HCV genotype 1 infection

From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

  Baseline SVR 12 p value
Platelets (10E3 μl-1) 171 ± 81 173 ± 76 0.8913
Total bilirubin (mg dl-1) 1.2 ± 1.0 0.7 ± 0.4 0.0052
INR 1.03 ± 0.12 1.06 ± 0.21 0.4964
Creatinine (mg dl-1) 0.77 ± 0.18 0.80 ± 0.17 0.5529
  1. Data are expressed as means ± SD
  2. SVR 12 sustained virological response at 12 weeks after end of treatment
  3. Boldface data statistically significant